227 related articles for article (PubMed ID: 25856215)
1. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
2. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
3. A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies.
Chazenbalk GD; Wang Y; Guo J; Hutchison JS; Segal D; Jaume JC; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 1999 Feb; 84(2):702-10. PubMed ID: 10022441
[TBL] [Abstract][Full Text] [Related]
4. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
5. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
6. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
[TBL] [Abstract][Full Text] [Related]
8. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
Ochi Y; Nagamune T; Nakajima Y; Ishida M; Kajita Y; Hachiya T; Ogura H
Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
[TBL] [Abstract][Full Text] [Related]
9. Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.
Misharin AV; Nagayama Y; Aliesky HA; Rapoport B; McLachlan SM
Endocrinology; 2009 Jun; 150(6):2948-56. PubMed ID: 19264867
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
11. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
Kim WB; Cho BY; Park HY; Lee HK; Kohn LD; Tahara K; Koh CS
J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
[TBL] [Abstract][Full Text] [Related]
12. Studies of possible antiidiotypic control mechanisms in Graves' disease.
Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
[TBL] [Abstract][Full Text] [Related]
13. Antithyrotropin antibodies in the sera of Graves' disease patients.
Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
[TBL] [Abstract][Full Text] [Related]
14. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
15. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease.
Kita M; Ahmad L; Marians RC; Vlase H; Unger P; Graves PN; Davies TF
Endocrinology; 1999 Mar; 140(3):1392-8. PubMed ID: 10067867
[TBL] [Abstract][Full Text] [Related]
16. Graves' disease in severe combined immunodeficient mice.
Soliman M; Kaplan E; Straus F; Fisfalen ME; Hidaka Y; Guimaraes V; DeGroot LJ
J Clin Endocrinol Metab; 1995 Oct; 80(10):2848-55. PubMed ID: 7559863
[TBL] [Abstract][Full Text] [Related]
17. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
18. Practical applications of studies on the TSH receptor and TSH receptor autoantibodies.
Furmaniak J; Sanders J; Sanders P; Miller-Gallacher J; Ryder MM; Rees Smith B
Endocrine; 2020 May; 68(2):261-264. PubMed ID: 32472423
[TBL] [Abstract][Full Text] [Related]
19. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
